News
Sixfold Bioscience to Present at RNA Therapeutics 2025
LONDON, United Kingdom, 05th February, 2025 — Sixfold Bioscience today announced that Dr Søren Ottosen, VP of Research, will join a panel session and present research on the company’s RNA delivery system at the upcoming conference: ‘RNA Therapeutics 2025: Advancing the next generation of genetic medicine through RNA based therapies’.
The two day summit held in London on the 10-11th of February 2025 will cover a range of topics on oligonucleotides and will feature leading industry experts from the RNA field, including: Roche, Moderna, J&J, Eli Lilly, GSK and Korro Bio.
Presentation: February 10th, 13:20pm (GMT)
Panel: February 10th, 15:50 (GMT)
Sixfold Bioscience is solving one of the most critical challenges preventing the greater utilisation of RNA: delivery. Using advanced AI/ML, automated chemistry and high throughput screening, Sixfold is learning the language that encodes RNA destination and unlocking new cell types for treatment.
